Trial Profile
A Phase II Clinical and Translational Study of STA-9090 in Patients With Refractory Metastatic Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2015
Price :
$35
*
At a glance
- Drugs Ganetespib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 25 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.